Lori J. West
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lori J. West has a total of 342 co-authors. Here are the top co-authors by number of shared publications:
- Bruce Motyka
Department of Pediatrics, University of Alberta, Edmonton, AB, Canada
13 shared publications - Anne Halpin
Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada; Alberta Precision Laboratories, Edmonton, Alberta, Canada; Canadian Donation and Transplantation Research Program, Alberta Transplant Institute, University of Alberta, Edmonton, Alberta, Canada
7 shared publications - Christopher W. Cairo
Department of Chemistry, University of Alberta, Edmonton, Alberta, Canada
7 shared publications - Kesheng Tao
Alberta Transplant Institute and Canadian Donation and Transplantation Research Program, Edmonton, Canada; Dept. of Pediatrics, University of Alberta, Edmonton, Alberta, Canada
7 shared publications - Peter J. Cowan
Immunology Research Centre St. Vincent's Hospital Melbourne Victoria Australia
7 shared publications - Todd L. Lowary
Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan
7 shared publications
Latest Publications
- Open Access
- 24 September 2026
- Published by Springer Nature in Research Square
Biological recognition of mirror-image glycans
Glycans form the outermost molecular interface of cells across all kingdoms of life, mediating recognition between organisms and their immune systems. Hypothetical mirror organisms would display glycans of reversed chirality, potentially impairing molecular recognition and contributing to proposed immune-evasion risks. Assessing DNA-encoded multivalent glycan arrays in settings ranging from purified proteins to mice, we found widespread recognition of mirror-image glycans by extant glycan-binding proteins, including recognition of L-glucose and L-galactose by the human immune receptor DC-SIGN. Mirror glycans were also selectively recognized by human immune cells and natural IgM antibodies and exhibited stereochemistry-dependent biodistribution in mice. Thus, glycan recognition can cross the chiral divide, revealing an unexpected molecular interface through which existing life could recognize and interact with hypothetical mirror life.
- 24 September 2026
- Published by Springer Nature in Research Square
Open AccessBiological recognition of mirror-image glycans
Glycans form the outermost molecular interface of cells across all kingdoms of life, mediating recognition between organisms and their immune systems. Hypothetical mirror organisms would display glycans of reversed chirality, potentially impairing molecular recognition and contributing to proposed immune-evasion risks. Assessing DNA-encoded multivalent glycan arrays in settings ranging from purified proteins to mice, we found widespread recognition of mirror-image glycans by extant glycan-binding proteins, including recognition of L-glucose and L-galactose by the human immune receptor DC-SIGN. Mirror glycans were also selectively recognized by human immune cells and natural IgM antibodies and exhibited stereochemistry-dependent biodistribution in mice. Thus, glycan recognition can cross the chiral divide, revealing an unexpected molecular interface through which existing life could recognize and interact with hypothetical mirror life.
- Open Access
- 25 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17
An atlas of human siglecs integrates expression, affinity, and cis/trans sialoglycan recognition profiles
All living cells have a sugar-coat that facilitates communication. Sialic acids cap mammalian glycans and are recognized by immune cells through sialic acid-binding immunoglobulin-like lectins (Siglecs) that regulate signaling by their cytoplasmic motifs. Inconsistent reports of Siglecs expression and sialoglycan recognition limit their therapeutic potential. Here we investigate 14 functional human Siglecs for their expression, glycan interactions and affinities. SIGLEC mRNA is broad in blood-derived monocytes and dendritic cells, restricted in natural-killer/B cells and absent in T cells, with similar Siglec-proteins expression in splenocytes. Binding to 114 glycans across 274 glycan microarrays, 220 splenocytes-assays and 132 cell-based arrays, reveal Siglecs functional relationships. Siglec-sialoglycan interactions are affected by sialic acid type (N-acetylneuraminic acid and N-glycolylneuraminic acid), 9-O-acetylation, linkage, sulfation, and carrier, are of varying affinities ( ~ 10 nM to µM/mM), and cis interactions are key regulatory features. This functional atlas enhances Siglecs potential as biomarkers and immunotherapy targets, switches or immune checkpoints for cancer and other diseases.
- 25 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17
Open AccessAn atlas of human siglecs integrates expression, affinity, and cis/trans sialoglycan recognition profiles
All living cells have a sugar-coat that facilitates communication. Sialic acids cap mammalian glycans and are recognized by immune cells through sialic acid-binding immunoglobulin-like lectins (Siglecs) that regulate signaling by their cytoplasmic motifs. Inconsistent reports of Siglecs expression and sialoglycan recognition limit their therapeutic potential. Here we investigate 14 functional human Siglecs for their expression, glycan interactions and affinities. SIGLEC mRNA is broad in blood-derived monocytes and dendritic cells, restricted in natural-killer/B cells and absent in T cells, with similar Siglec-proteins expression in splenocytes. Binding to 114 glycans across 274 glycan microarrays, 220 splenocytes-assays and 132 cell-based arrays, reveal Siglecs functional relationships. Siglec-sialoglycan interactions are affected by sialic acid type (N-acetylneuraminic acid and N-glycolylneuraminic acid), 9-O-acetylation, linkage, sulfation, and carrier, are of varying affinities ( ~ 10 nM to µM/mM), and cis interactions are key regulatory features. This functional atlas enhances Siglecs potential as biomarkers and immunotherapy targets, switches or immune checkpoints for cancer and other diseases.
- 23 April 2026
- Published by American Society of Hematology in Blood
- Vol. 147 (17) , 1891-1892
Engineering ABO histocompatibility in transplant and beyond
- 23 April 2026
- Published by American Society of Hematology in Blood
- Vol. 147 (17) , 1891-1892
Engineering ABO histocompatibility in transplant and beyond
- 18 March 2026
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 45 (7) , 1103-1107
Advancing ABO-histocompatibility: Impact of multiplexed ABO antibody immunoassay to increase precision in pediatric heart transplantation
- 18 March 2026
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 45 (7) , 1103-1107
Advancing ABO-histocompatibility: Impact of multiplexed ABO antibody immunoassay to increase precision in pediatric heart transplantation
- Open Access
- 6 December 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (4) , 850-858
Posttransplant outcomes with prolonged donor heart ischemic time in the pediatric population
- 6 December 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (4) , 850-858
Open AccessPosttransplant outcomes with prolonged donor heart ischemic time in the pediatric population
- Open Access
Evaluation of Multiplexed Liquid Glycan Array (LiGA) for Serological Detection of Glycan-binding Antibodies
We test the performance of the multiplexed liquid glycan array (LiGA) technology in serological assays. Specifically, we use LiGA to detect ABO blood group antibodies in human serum. This LiGA, which we name ABO-LiGA, contains ABO blood group trisaccharide glycans with an ethylazido aglycone conjugated to groups of ten multi-barcoded M13 particles carrying dibenzocyclooctyne (DBCO) on p8 proteins. ELISA clonal binding assays to anti-A/B antibodies confirmed the functional performance of ABO-clones and aligned with next-generation sequencing (NGS) of the mixed clones. Multiple DNA-barcoded technical replicates in LiGA allow for quantification of reproducibility and robustness as determined by the Z’-score using NGS. We then tested ABO-LiGA for specific detection of IgG and IgM anti-A and anti-B IgG and IgM antibodies in human serum samples. Comparison of antibody binding responses in sera from 31 healthy donors to ABO-LiGA with an ABO-Luminex-based method revealed consistent responses to LiGA-ABO but also minor deficiencies of ABO-LiGA such as low robustness of the current assay format and a limited ability to detect low intensity antibody responses. Some results point to undesired interactions of serum antibodies with small-footprint glycans conjugated to phage via the bulky DBCO moiety. This report illuminates the path for future development of LiGA-based serological assays and suggests the need to develop alternative methods for conjugating glycans to phage to avoid liabilities of the hydrophobic DBCO moiety.
Open AccessEvaluation of Multiplexed Liquid Glycan Array (LiGA) for Serological Detection of Glycan-binding Antibodies
We test the performance of the multiplexed liquid glycan array (LiGA) technology in serological assays. Specifically, we use LiGA to detect ABO blood group antibodies in human serum. This LiGA, which we name ABO-LiGA, contains ABO blood group trisaccharide glycans with an ethylazido aglycone conjugated to groups of ten multi-barcoded M13 particles carrying dibenzocyclooctyne (DBCO) on p8 proteins. ELISA clonal binding assays to anti-A/B antibodies confirmed the functional performance of ABO-clones and aligned with next-generation sequencing (NGS) of the mixed clones. Multiple DNA-barcoded technical replicates in LiGA allow for quantification of reproducibility and robustness as determined by the Z’-score using NGS. We then tested ABO-LiGA for specific detection of IgG and IgM anti-A and anti-B IgG and IgM antibodies in human serum samples. Comparison of antibody binding responses in sera from 31 healthy donors to ABO-LiGA with an ABO-Luminex-based method revealed consistent responses to LiGA-ABO but also minor deficiencies of ABO-LiGA such as low robustness of the current assay format and a limited ability to detect low intensity antibody responses. Some results point to undesired interactions of serum antibodies with small-footprint glycans conjugated to phage via the bulky DBCO moiety. This report illuminates the path for future development of LiGA-based serological assays and suggests the need to develop alternative methods for conjugating glycans to phage to avoid liabilities of the hydrophobic DBCO moiety.
- Open Access
- 29 April 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (8) , 1788-1791
Rejection and graft vasculopathy secondary to effects of Crohn's disease in a heart-transplanted child
- 29 April 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (8) , 1788-1791
Open AccessRejection and graft vasculopathy secondary to effects of Crohn's disease in a heart-transplanted child
- Open Access
- 10 April 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (9) , 1884-1894
Multiplex bead immunoassay in ABO-A2-incompatible kidney transplantation
- 10 April 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (9) , 1884-1894
Open AccessMultiplex bead immunoassay in ABO-A2-incompatible kidney transplantation
- Open Access
- 6 March 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (6) , 1180-1192
ABO-A antibody induction in mice is T cell-dependent, estrogen-independent, and modulated by CD22
- 6 March 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (6) , 1180-1192
Open AccessABO-A antibody induction in mice is T cell-dependent, estrogen-independent, and modulated by CD22
- 23 January 2024
- Published by Wolters Kluwer Health in Transplantation
- Vol. 108 (2) , e20
“Real Women”: The Shared Responsibility to Use Gender-affirming Language
- 23 January 2024
- Published by Wolters Kluwer Health in Transplantation
- Vol. 108 (2) , e20
“Real Women”: The Shared Responsibility to Use Gender-affirming Language